Daniel Markowitz from Evercore ISI sets a new price target for NYSE:WST at $390, indicating a 26.1$1.96, beating estimates by 17.4%.The company raises its full-year EPS outlook to $7.06 to$7.11, driven by strong demand and favorable foreign exchange conditions.West Pharmaceutical Services, Inc. (NYSE:WST) is a leading provider of innovative solutions for injectable drug administration. The company specializes in the de ...